Maharajah Ponnaiah
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Year:
2026
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no effective curative therapies. Necroptosis, a regulated necrotic cell death pathway controlled by receptor-interacting protein kinase 1 (RIPK1), has emerged as a potential driver of inflammation and fibrosis in chronic liver disorders. We investigated the role of necroptosis in PSC and whether RIPK1 inhibition could modify disease course and progression. Spatial profiling of human PSC biopsies revealed that necroptosis primarily affects cholangiocytes, while apoptosis was more frequent in hepatocytes and nonbiliary cells. In vitro, necroptosis inhibition protected cholangiocytes, and RIPK1 deletion conferred resistance to TNF-mediated cytotoxicity. In a murine model of PSC, pharmacological RIPK1 inhibition reduced cholestatic injury, hepatic inflammation, and biliary fibrosis. Multiomic analyses comprehensively demonstrated reprogramming toward wild-type–like profiles following treatment. These findings identify necroptosis as a critical effector in PSC and highlight RIPK1 inhibition as a promising disease-modifying approach, opening the door to targeted necroptosis-based therapies for this otherwise untreatable disease.
Year:
2025
Fanconi Anemia (FA) is a genetic disorder marked by bone marrow failure and cancer risk. FA features continuous activation of the p53 pathway, leading to an exacerbated cellular response to stress and DNA damage and significantly altering cellular metabolism. Here, we pointed out for the first time the overexpression of ZMAT3, an RNA-binding protein, in murine FA-deficient hematopoietic cells. To elucidate the functions of ZMAT3 in the context of FA, we employed a two-pronged experimental approach. Initially, hematopoietic stem cells from FA knockout (FA-KO) mice with targeted downregulation of ZMAT3 and a human fibroblast cell line derived from an FA patient. Combining functional and Omics approaches, our study uncovers the critical involvement of ZMAT3 in enhancing the survival of FA-deficient cells by modulating sphingolipid metabolism and ferroptosis. ZMAT3 emerges as a pivotal factor in mitigating hematopoietic stem cell exhaustion during the initial stages of FA.
Year:
2024
Year:
2020
Collaborators (11)
Lawrence Serfaty
-
Ida Chiara GUERRERA
Head Necker Proteomics
INSERM
Franck Verdonk
Stanford University
Axelle Cadoret
INSERM
Nicolas Chignard
Associate Professor
Sorbonne Université
MARIE LHOMME
Head of Lipidomics
-
Marie-Laure Arcangeli
Université Paris-Saclay
Jérémie Gautheron
INSERM
Camille Lobry
Principal Investigator
-
Ines Metatla
INSERM
Tounsia AIT SLIMANE
Full Professor
Sorbonne Université Campus Pierre et Marie Curie
Make your next move.
Prepare your application
Review drafts before you send them.